IL1B and diabetes mellitus: Lastly, the robustness of hubs was determined by challenging islets with cytokine cocktails (IL-1β/IL-6 or IL-1β/TNF-α) to re-create the pro-inflammatory milieu thought to be associated with diabetes (O’Neill et al., 2013).